PMID: 18193578Jan 16, 2008Paper

A short-term effect of lovastatin on lipoprotein metabolism in patients with cerebrovascular lesions concomitant with diabetes mellitus II type

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
G Kh BozhkoT G Pertseva

Abstract

Changes of lipoprotein (LP) metabolism after lovastatin therapy (20 mg/day for 2 months) have been studied in patients with cerebrovascular lesions (CBL) concomitant with diabetes mellitus type 2 (DM-2) and in CBL patients without DM-2. Initial effect of lovastatin appeared in decreasing chilomicrone content in both groups of patients. A distinct trend towards restoration of processes converting apoA-containing LP being accompanied by normalization of function of the peripheral lipoprotein lipase bound form was observed. The data obtained support an opinion about rationality of lovastatin treatment of dyslipidemias in CBL concomitant with DM-2 as well as of cardiovascular pathology.

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Related Papers

Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
José María De la Roca-ChiapasJosé Jasso
The European Journal of General Practice
Lielith J Ubink-VeltmaatBetty Meyboom-de Jong
Revista médica del Instituto Mexicano del Seguro Social
Celia Linares-VieyraLuis Enrique Rodríguez-de Mendoza
Ukrainskiĭ biokhimicheskiĭ zhurnal
G Kh BozhkoT G Pertseva
© 2021 Meta ULC. All rights reserved